Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1874-4702|2|3|263-284

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.2, Iss.3, 2009-11, pp. : 263-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypoxia Helps Glioma to Fight Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 3, 2009-01 ,pp. : 381-390

Bentham Science Publishers

Access to resources Recommend Favorite

Antiangiogenic Therapy in Malignant Glioma: Promise and Challenge

By  

Current Pharmaceutical Design, Vol. 13, Iss. 35, 2007-12 ,pp. : 3545-3558

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance

By  

Current Molecular Pharmacology, Vol. 3, Iss. 1, 2010-01 ,pp. : 37-52

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for malignant glioma

By Mason Warren P  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 81-94

Informa Healthcare

Access to resources Recommend Favorite

Epigenetic Regulation of Epithelial-Mesenchymal Transition by Hypoxia in Cancer: Targets and Therapy

By  

Current Pharmaceutical Design, Vol. 21, Iss. 10, 2015-03 ,pp. : 1272-1278

Bentham Science Publishers

Access to resources Recommend Favorite